Human cytomegalovirus infection is a novel etiology for essential hypertension

Medical Hypotheses

Volumn 76, Issue 5, 2011, Pages 682-684

  Zhang, Mingming ^a   Yang, Yaoguo ^b   Yang, Xinchun ^a   Cai, Jun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN;

ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CYTOMEGALOVIRUS INFECTION; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; HEART TRANSPLANTATION; HUMAN; HUMAN CYTOMEGALOVIRUS; IN VIVO STUDY; INFLAMMATION; ISCHEMIC HEART DISEASE; NONHUMAN; PATHOGENESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SYNTHESIS; VASODILATATION;

CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIUM; HUMANS; HYPERTENSION; IMMUNE SYSTEM; INFLAMMATION; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NITRIC OXIDE; OXIDATIVE STRESS; RENIN-ANGIOTENSIN SYSTEM; RISK; RISK FACTORS;

HUMAN HERPESVIRUS 5;

EID: 79954415079     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.01.032     Document Type: Article

References (54)

1. Pierdomenico S.D., Di Nicola M., Esposito A.L., et al. Prognostic value of different indices of blood pressure variability in hypertensive patients. Am J Hypertens 2009, 22(8):842-847.
2. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119(3):480-486.
3. Stumpf C., John S., Jukic J. Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension. J Hypertens 2005, 23:995-1000.
4. Bolovan-Fritts C.A., Trout R.N. High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage. Blood 2007, 110:1857-1863.
5. Kristal B., Shurtz-Swirski R., et al. Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension. J Hypertens 1998, 11:921-928.
6. Fermandez-Real J.M., Vayreda M., Rechart C., et al. Lating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently health men and women. J Clin Endocrinol Metab 2001, 86:1154-1159.
7. Moon S.K., Cha B.Y., Kim C.H. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NK-kappaB and AP-1:involvement of the rat dependent pathway. J Cell Physiol 2004, 198:417-427.
8. Vecchione C., Frati A., Di Pardo A., et al. Tumor necrosis factor-α mediates hemolysis-induced vasoconstriction and the cerebral vasospasm evoked by subarachnoid hemorrhage. Hypertension 2009, 54:150-156.
9. Crough T., Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 2009, 22(1):76-98.
10. Berk T., Gordon S.J., Choi H.Y., Cooper H.S. Cytomegalovirus infection of the colon: a possible role in exacerbation of inflammatory bowel disease. Am J Gastroenterol 1985, 80:355-360.
11. Grattan M.T., Moreno-Cabral C.E., Starnes V.A., Oyer P.E., Stinson E.B., Shumway N.E. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989, 261:3561-3566.
12. Speir E., Modali R., Huang E.S., et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994, 265:391-394.
13. Speir E., Modali R., Huang E.S., et al. Interaction of human cytomegalovirus with p53: possible role in coronary restenosis. Scand J Infect Dis Suppl 1995, 99:78-81.
14. Zhou Y.F., Leon M.B., Waclawiw M.A., Popma J.J., Yu Z.X., Finkel T., Epstein S.E. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996, 335(9):624-630.
15. Nieto F.J., Sorlie P., Farzadegan H., Melnick J.L., Comstock G.W., Szklo M. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 1996, 94(5):922-927.
16. Loenen W.A., Bruggeman C.A., Wiertz E.J. Immune evasion by human cytomegalovirus: lessons in immunology and cell biology. Semin Immunol 2001, 13:41-49.
17. Streblow D.N., Soderberg-Naucler C., Vieira J. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 1999, 99:511-520.
18. Dumortier J., Streblow D.N., Moses A.V., et al. Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing. J Virol 2008, 82(13):6524-6535.
19. Ignarro L.J., Bush P.A., Buga G.M., Wood K.S., Fukuto J.M., Rajfer J. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1990, 70:843-850.
20. Moncada S., Rees D.D., Schulz R., Palmer R.M. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci 1991, 88:2166-2170.
21. Priviero F.B., Zemse S.M., Teixeira C.E., Webb R.C. Oxidative stress impairs vasorelaxation induced by the soluble guanylyl cyclase activator BAY 41-2272 in spontaneously hypertensive rats. J Hypertens 2009, 22:493-499.
22. Gerassimou C., Kotanidou A., Zhou Z., Simoes D.C., Roussos C., Papapetropoulos A. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species. Br J Pharmacol 2007, 150:1084-1091.
23. Shen Y.H., Utama B., Wang J., Gan Y., Wang X., Wang J., et al. Human cytomegalovirus inhibits Akt-mediated eNOS activation through upregulating PTEN (phosphatase and tensin homolog deleted on chromosome 10). Cardiovasc Res 2006, 69(2):502-511.
24. Weis M., Kledal T.N., Lin K.Y., et al. Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation 2004, 109(4):500-505.
25. Grahame-Clarke C., Chan N.N., Andrew D., et al. Human cytomegalovirus seropositivity is associatedwith impaired vascular function. Circulation 2003, 108:678-683.
26. Grahame-Clarke C. Human cytomegalovirus, endothelial function and atherosclerosis. Herpes 2005, 12(2):42-45.
27. Petrakopoulou P.K.M., Pehlivanli S., Meiser B., Reichart B., von Scheidt W., Weis M. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function. Circulation 2004, 110(11 Suppl. 1):II207-212.
28. Landmesser U., Cai H., Dikalov S., et al. Role of p47 (phox) in vascular oxidative stress and hypertension caused by angiotensin. Hypertension 2002, 40:511-515.
29. Chobanian A.V., Alexander R.W. Exacerbation of atherosclerosis by hypertension. Potential mechanism and clinical implications. Arch Intern Med 1996, 156:1952-1956.
30. Alvarez Y., Pérez-Girón J.V., Hernanz R., et al. Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats. J Pharmacol Exp Ther 2007, 321:381-388.
31. Bech Laursen J., Rajagopalan S., Tarpey M., et al. A role of superoxide in angiotensin II - but not catecholamine-induced hypertension. Circulation 1997, 95:588-589.
32. Kaikobad Irani Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000, 87:179-183.
33. Cosentino F., Sill J.C., Katusić Z.S. Role of superoxide anions in the mediation of endothelial dependent contractions. Hypertension 1994, 23:229-235.
34. Resta T.C., Broughton B.R., Jernigan N.L. Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 2008, 295:L515-L529.
35. Grilli M., Chiu J.J., Lenardo M.J. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993, 143:1-62.
36. Collins T. Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest 1993, 68:499-508.
37. Juilfs D.M., Soderling S., Burns F., Beavo J.A. Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs). Rev Physiol Biochem Pharmacol 1999, 135:67-104.
38. Vila E., Salaices M. Cytokines and vascular reactivity in resistance arteries. Am J Physiol Heart Circ Physiol 2005, 288:H1016-H1021.
39. Cinatl J., Vogel J.U., Kotchetkov R., Scholz M., Doerr H.W. Proinflammatory potential of cytomegalovirus infection: specific inhibition of cytomegalovirus immediate-early expression in combination with antioxidants as a novel treatment strategy?. Intervirology 1999, 42:419-424.
40. Speir E., Yu Z.X., Ferrans V.J., Huang E.S., Epstein S.E. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ Res 1998, 83:210-216.
41. Poole E., Atkins E., Nakayama T. The UL144 gene product of human cytomegalovirus activates NFκB via a TRAF6-dependent mechanism. EMBO J 2006, 25:4390-4399.
42. DeMeritt I.B., Milford L.E., Yurochko Y.A. Activation of the NF-κB Pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter. J Virol 2004, 78:4498-4507.
43. Collins T., Cybulsky M.I. NF-κB: pivotal mediator or innocent bystander in atherogenesis?. J Clin Invest 2001, 107:255-264.
44. Bellas R.E., Lee J.S., Sonenshein G.E. Expression of a constitutive NF-κB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J Clin Invest 1995, 96:2521-2527.
45. Sachetelli S., Liu Q., Zhang S.L., et al. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int 2006, 69:1016-1023.
46. Berry C., Hamilton C.A., Brosnan M.J., et al. Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internalmammary arteries. Circulation 2000, 101:2206-2212.
47. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994, 74:1141-1148.
48. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADPH and NADPH oxide synthase in hypertension. Circ Res 1994, 74:1141-1148.
49. Gryglewski R.J., Palmer R.M., Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986, 320:454-456.
50. Cheng J., Ke Q., Jin Z., et al. Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog 2009, 5(5):e1000427.
51. Rodríguez-Iturbe B., Quiroz Y., Nava M., et al. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 2002, 282:F191-F201.
52. Tomasz J., Hoch N.E., Brown K.A., et al. Role of the T cells in the genesis of angiotensin II-induced hypertension and vascular dysfunction. JEM 2007, 204:2449-2460.
53. Chon Helena, CarloGaillard A.J.M., Gaillard, Brenda B. Van der Meijden. Broadly altered gene expression in blood Leukocytes in essential hypertension is absent during treatment. Hypertension 2004, 43:947-951.
54. Yasunari K., Maeda K., Nakamura M., Yoshikawa J. Oxidative stress in leukocytes in a possible link between blood pressure, blood glucose, and C-reacting protein. Hypertension 2002, 39:777-780.